The Cancer Vaccine Center is Developing
Safe, Effective Vaccines for Patients With Cancer
Welcome to the Cancer Vaccine Center (CVC). We are developing safe and effective vaccines for patients with cancer. The CVC maintains an integrated program of scientific discovery, preclinical vaccine development and clinical investigation. As part of Dana-Farber Cancer Institute, the CVC is affiliated with Harvard Medical School and Dana-Farber/Harvard Cancer Center.
CVC Feature
Catherine Wu, M.D.
Catherine Wu is co-recipient of the Blavatnik Family Foundation gift of $5 million to support cancer vaccine research at the Broad Institute. Together with Dr. Nir Hacohen of MGH, she will undertake a new program to develop personalized cancer vaccines using genome-based identification of neoantigens. The goal of the research is to direct a person's own immune system to attack and eradicate a tumor, based on the presence of mutated tumor proteins found only within the tumor cells. If successful, the development of personalized cancer vaccines will transform the treatment of cancer.
